![David M. Fineman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David M. Fineman
Chief Executive Officer at
KINEMED INC
Profile
David M.
Fineman is the founder of KineMed, Inc. (founded in 2001) where he currently serves as the Chairman & Chief Executive Officer.
He was also the founder of Quark Pharmaceuticals, Inc. (founded in 1993) where he served as a Director.
Dr. Fineman's former job includes being the Acting Chief Financial Officer at SuperGen, Inc. (1990-2013).
Dr. Fineman's education history includes an undergraduate degree from the University of Maryland (conferred in 1966) and a graduate degree from The New School for Social Research.
David M. Fineman active positions
| Companies | Position | Start |
|---|---|---|
| KINEMED INC | Chief Executive Officer | 29/08/2013 |
Former positions of David M. Fineman
| Companies | Position | End |
|---|---|---|
Quark Pharmaceuticals, Inc.
 Quark Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers and develops novel RNAi-based therapeutics | Founder | - |
SuperGen, Inc.
 SuperGen, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops drugs, diagnostics and other therapeutic products | Director of Finance/CFO | - |
Training of David M. Fineman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
60
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
SuperGen, Inc.
SuperGen, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops drugs, diagnostics and other therapeutic products | Health Technology |
KineMed, Inc.
 KineMed, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes biomarker platform technology | Commercial Services |
Quark Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers and develops novel RNAi-based therapeutics | Health Technology |
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The New School for Social Research
 The New School for Social Research Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- David M. Fineman
